Klaus Edvardsen
Corporate Officer/Principal presso NYKODE THERAPEUTICS
Profilo
Klaus Edvardsen is currently the Chief Development Officer at Nykode Therapeutics ASA since 2022.
Prior to this, he was the Chief Development Officer at CureVac NV from 2021 to 2022.
He also served as the SVP& Head-Global Medicines Development Oncology at AstraZeneca PLC.
Dr. Edvardsen holds a doctorate degree from the University of Copenhagen.
Posizioni attive di Klaus Edvardsen
| Società | Posizione | Inizio |
|---|---|---|
| NYKODE THERAPEUTICS | Corporate Officer/Principal | 01/07/2022 |
Precedenti posizioni note di Klaus Edvardsen
| Società | Posizione | Fine |
|---|---|---|
| CUREVAC N.V. | Corporate Officer/Principal | 30/06/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Formazione di Klaus Edvardsen
| University of Copenhagen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| CUREVAC N.V. | Health Technology |
| NYKODE THERAPEUTICS | Health Technology |
- Borsa valori
- Insiders
- Klaus Edvardsen
